From Science Daily website (see original article).
ScienceDaily (Nov. 29, 2012) — In a recent publication,
researchers of the Computational Biology group at the Luxembourg Centre
for Systems Biomedicine showed that neuro-inflammation plays a crucial
role in initiating prion disease.
Prion diseases
represent a family of neurodegenerative disorders associated with the
loss of brain cells and caused by proteins called prions (derived from
‘protein’ and ‘infection’).
The diseases are found in both humans and
animals, such as Creutzfeld-Jakob disease and mad cow disease
respectively.
Although mostly harmless, prions can transform into
infectious agents, which accumulate in the brain and destroy the nervous
tissue.
But how exactly does the accumulation of prions cause
destruction of the brain? “Understanding the process by which prions
destroy neurons is critical for finding a cure for prion disease”, says
Isaac Crespo, first author of the publication.
He and his colleagues
tackled this question with a computational approach: they ran their own
computer programmes on experimental data generated by other research
groups, and identified a set of 16 proteins that seems to control the
onset of the disease.
Interestingly, almost all of these proteins have
known functions in neuro-inflammation.
“What we consider
remarkable and constitutes our main finding, is the key role that
neuro-inflammation plays in initiating prion disease.
This finding is
not only relevant for prion diseases, but also for other ‘protein
misfolding diseases’ such as Parkinson’s and Alzheimer diseases” says
Prof. Dr. Antonio del Sol, group leader of the Computational Biology
group.
Since its publication on October 15th, Crespo’s
paper was accessed so frequently, that it received the mark ‘Highly
Accessed’, only awarded to articles that are downloaded very frequently.
The strong interest that scientists are showing for these research
findings reflects the urgency with which researchers are trying to
understand prion diseases for which there is no cure until today.
Nessun commento:
Posta un commento